PDIA4 and gastric cancer: Clinical studies have shown that the level of ApoB/ApoA1 in gastric cancer patients is negatively correlated with the survival rate, while PDIA4 is positively correlated with the survival rate of gastric cancer patients (Ma et al., 2018).